ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,626Medicare Part D Prescriptions Filled, Including Refills

Rank: 279 out of 1000

$522K Total Retail Price of All Prescriptions

Rank: 244 out of 1000

387 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 6,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 417 300 1 3
HYDROCODONE-ACETAMINOPHEN 406 332 S3 2 1
OMEPRAZOLE 317 218 3 2
HYDROCHLOROTHIAZIDE 285 212 4 9
LEVOTHYROXINE SODIUM 255 169 5 4
AMLODIPINE BESYLATE 255 200 5 6
FUROSEMIDE 222 197 7 7
METFORMIN HCL 193 138 8 8
PRAVASTATIN SODIUM 181 125 9 12
LISINOPRIL 156 100 10 5
ATORVASTATIN CALCIUM 154 124 11 18
NEXIUM 147 109 12 23
METOPROLOL SUCCINATE 145 115 13 21
CARVEDILOL 142 83 14 15
GLIMEPIRIDE 126 105 15 34
ZOLPIDEM TARTRATE 122 107 16 16
MELOXICAM 121 71 17 14
PANTOPRAZOLE SODIUM 112 85 18 28
GABAPENTIN 107 88 19 11
TRAMADOL HCL 102 71 20 13
POTASSIUM CHLORIDE 100 69 21 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 64 22 20
WARFARIN SODIUM 91 61 23 22
METFORMIN HCL ER 90 76 24 44
METOPROLOL TARTRATE 89 53 25 19
TAMSULOSIN HCL 84 78 26 33
IBUPROFEN 83 55 27 94
CITALOPRAM HBR 83 65 27 17
DONEPEZIL HCL 82 82 29 32
ESCITALOPRAM OXALATE 81 65 30 60
LOSARTAN POTASSIUM 81 67 30 25
ZETIA 80 63 32 95
CLONIDINE HCL 68 49 33 27
SERTRALINE HCL 68 52 33 26
ALENDRONATE SODIUM 64 62 35 57
LOSARTAN-HYDROCHLOROTHIAZIDE 60 25 36 38
ALLOPURINOL 60 42 36 31
RANITIDINE HCL 60 49 36 37
TRIAMTERENE-HCTZ 60 47 36 48
VENLAFAXINE HCL ER 59 29 40 124
CRESTOR 56 28 41 30
ATENOLOL 56 45 41 24
CLOPIDOGREL 55 48 43 35
DIOVAN HCT 54 40 44 96
TRAZODONE HCL 53 30 45 29
HUMULIN 70-30 52 38 46 131
FLUTICASONE PROPIONATE 50 44 47 40
LANTUS SOLOSTAR 50 40 47 120
AZITHROMYCIN 50 39 47 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.